Conditional Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Era of Tyrosine Kinase Inhibitors

BACKGROUND: Tyrosine kinase inhibitors (TKI) significantly improve survival in patients with chronic myeloid leukemia in chronic phase (CML-CP). Conditional probability provides survival information in patients who have already survived for a specific period of time after treatment. METHODS: Cumulat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Sasaki, Koji, Kantarjian, Hagop, Jain, Preetesh, Jabbour, Elias, Ravandi, Farhad, Konopleva, Marina, Borthakur, Gautam, Takahashi, Koichi, Pemmaraju, Naveen, Daver, Naval, Pierce, Sherry, O’Brien, Susan, Cortes, Jorge E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707980/
https://ncbi.nlm.nih.gov/pubmed/26479889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29745
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados